NONAGON News
8 articles
Upgraded N9+ virtual care device offers patients enhanced otoscope ear exam for ease of use & high-definition visuals - NONAGON
Nonagon has announced the release of the N9+, a remote care device that allows users to conduct medical exams from their smartphones. The N9+ comes with enhanced functionality and a simplified user experience, including an advanced Otoscope for ear, mouth, and throat exams. The device has received positive feedback from patients and physicians, and there is already significant interest in the upgraded version. Nonagon aims to make healthcare more user-friendly and accessible while providing physicians with reliable clinical data. Owners of the original N9 version can continue using it or upgrade to the N9+.
Customers
Vista Grande Villa Levels Up Senior Care with Transformative Virtual Technology - NONAGON
Vista Grande Villa has adopted Nonagons telehealth platform to expand its healthcare services for patients and residents. The integration of Nonagons technology allows for 24/7 access to patients healthcare providers, enabling remote examinations and communication between patients, caretakers, and healthcare organizations. The adoption of Nonagons platform was made possible through a grant awarded to Vista Grande Villa by the FCC COVID-19 Telehealth Program. The platform aims to reduce patients unnecessary risk of exposure to infectious diseases and other dangers related to leaving the facility during recovery. Vista Grande Villa is a non-profit senior living community offering various levels of care.
Customers
NONAGON Announces Series A Investment Funding Round Led by BIG Capital in Conjunction with New Chairman - NONAGON
Israeli startup Nonagon has achieved its Series A investment funding goal, led by new investor BIG Capital. The funding will support Nonagons efforts to connect patients with their primary care physicians through a remote examination device. In conjunction with the funding, Nonagon has appointed Josh Ghaim, Ph.D., as Chairman of the Board of Directors. Nonagon plans to expand its presence and increase sales in the US, enhancing the telehealth experience for patients. The funding will enable Nonagon to make healthcare more efficient and convenient for providers and patients. The company aims to provide affordable, handheld medical devices that work with consumers smartphones. The funding comes at a time when the healthcare industry is seeking technologies to improve the healthcare process. Nonagons vision is to make high-level medical care accessible to anyone, anywhere in the world.
InvestmentManagement ChangesExpand
Ignite Venture Studio Announces Partnership with Nonagon to Expand the Boundaries of Healthcare Through At-Home Diagnostics
Ignite Venture Studio has announced a new partnership with Nonagon to transform the delivery of virtual healthcare. The partnership will enhance Ignite Venture Studios telehealth platform with Nonagons breakthrough diagnostic technology, allowing consumers to conduct virtual medical examinations using a convenient device paired with their smartphone. The technology includes a digital stethoscope, otoscope, pulse oximeter, and infrared thermometer, providing physicians with essential data for accurate diagnosis and treatment. The partnership aims to make primary healthcare services easy and affordable for all American families. Ignite Venture Studio focuses on disrupting the digital health and beauty sectors and has a history of building successful brands in the health and beauty space.
Partners
New telehealth device makes home visits a virtual snap
Israeli startup Nonagon has developed the N9 nine-in-one home device for telemedicine, which performs various tests traditionally done in person by doctors. The portable device includes a stethoscope, otoscope, oximeter, and thermometer, among other features. Patients can send the results of their at-home checks directly to their physicians using Nonagons software. The device received FDA clearance and is available only by prescription. Nonagon aims to address the needs of an entire family or household, regardless of whether the patient has chronic conditions. The company is seeking business partners in the US and other regions to launch business pilots.
CustomersPartners
MyHomeDoc Announces Rebrand as NONAGON - Reflecting Commitment To Make Healthcare Accessible To All
Medical start-up MyHomeDoc has announced a rebranding and will now be known as NONAGON. The new branding will be effective immediately on all products, digital assets, and communications worldwide. The NONAGON name refers to a nine-sided polygon, symbolizing the nine physical exams that the N9 device can conduct. The device is FDA cleared, CE marked, and approved by the Israeli Ministry of Health. NONAGON aims to make healthcare more accessible and convenient through its affordable, high-quality healthcare services. The company was founded in 2016 with the goal of elevating the telehealth process. The rebranding aligns with the companys core values and motivations.
Customers
Israeli startup MyHomeDoc receives FDA approval for smartphone-based telemedicine
Israeli startup MyHomeDoc has received FDA approval for its smartphone-based telemedicine solution. The device, funded by Teva Pharmaceuticals and Sanara Ventures, allows for primary medical care testing and diagnosis from a smartphone. The FDA approval will enable MyHomeDoc to expand into global markets. The device utilizes four embedded sensors that interface with the users smartphone to provide readings of vital signs. Patients can receive immediate diagnosis, referral, or prescription from a certified physician based on the clinical data they send in real-time. MyHomeDoc CEO, Alon Natanson, sees the FDA approval as an important milestone for the companys advancement in telemedicine.
CustomersInvestment
Israeli digital health incubator has made first investment since launch
eHealth Ventures, an Israeli digital health incubator, has one portfolio business and is reviewing two more. The portfolio includes TikTalk2Me, a digital health company focused on speech therapy. The incubator is also considering a company focused on food allergies and another with a connected cap for insulin pens. The incubator program in Israel has attracted collaborations with companies like Medtronic, IBM, Johnson & Johnson, Teva, and Philips. The program provides budgets ranging from $500,000 to $800,000, with 85% of the funding coming from the government through a grant. The goal is to make Israeli startups competitive in the U.S. market.
Partners